Back
Adverum Biotechnologies, Inc. 10K Form
Sell
31
ADVM
Adverum Biotechnologies, Inc.
Last Price:
$4.18
Seasonality Move:
-11.49%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ADVM News And Ratings
See the #1 stock for the next 7 days that we like better than ADVM
ADVM Financial Statistics
Sales & Book Value
| Annual Sales: | $1M |
|---|---|
| Cash Flow: | $-28.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-2.53 |
| Price / Book: | 1.95 |
Profitability
| EPS (TTM): | -8.57440 |
|---|---|
| Net Income (TTM): | $-184.8M |
| Gross Margin: | $-2.7M |
| Return on Equity: | -558.69% |
| Return on Assets: | -128.25% |
Adverum Biotechnologies, Inc. Earnings Forecast
Key Adverum Biotechnologies, Inc. Financial Ratios
-
The Gross Profit Margin over the past 13 years for ADVM is -265.30%.
-
The Selling, General & Administrative Expenses for ADVM have been equal to 6,311.80% of Gross Profit Margin.
-
The Research & Development expenses have been 7,704.10% of Revenue.
-
The Net Earning history of ADVM is -13,092.70% of Total Revenues.
-
Per Share Earnings over the last 13 years have been positive in 6 years.
Adverum Biotechnologies, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ADVM |
| CUSIP: | 00773U |
| Website: | adverum.com |
Debt
| Debt-to-Equity Ratio: | -1.6 |
|---|---|
| Current Ratio: | 0.65 |
| Quick Ratio: | 0.58 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ADVM Technical Analysis vs Fundamental Analysis
Sell
31
Adverum Biotechnologies, Inc. (ADVM)
is a Sell
Is Adverum Biotechnologies, Inc. a Buy or a Sell?
-
Adverum Biotechnologies, Inc. stock is rated a SellThe current Adverum Biotechnologies, Inc. [ADVM] share price is $4.17. The Score for ADVM is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.